BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3440599)

  • 1. Neuroblastoma mass screening in infancy in Kyoto, Japan.
    Sawada T; Kawakatsu H; Sugimoto T; Horii Y; Kuroda K; Hosoi H; Saida T; Hino T; Michihata T
    Indian J Pediatr; 1987; 54(6):874-82. PubMed ID: 3440599
    [No Abstract]   [Full Text] [Related]  

  • 2. Mass screening of neuroblastoma in infancy.
    Sawada T; Todo S; Fujita K; Iino S; Imashuku S; Kusunoki T
    Am J Dis Child; 1982 Aug; 136(8):710-2. PubMed ID: 6808827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroblastoma. Mass screening for early detection and its prognosis.
    Sawada T; Kidowaki T; Sakamoto I; Hashida T; Matsumura T; Nakagawa M; Kusunoki T
    Cancer; 1984 Jun; 53(12):2731-5. PubMed ID: 6722733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Number and cure rate of neuroblastoma cases detected by the mass screening program in Japan: future aspects.
    Sawada T; Sugimoto T; Tanaka T; Kawakatsu H; Ishii T; Matsumura T; Horii Y
    Med Pediatr Oncol; 1987; 15(1):14-7. PubMed ID: 3561327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mass screening for neuroblastoma in Japan. Committee of the Neuroblastoma Mass Screening Study of the Japanese Society of Pediatric Oncology.
    Sawada T; Nagahara N; Yamamoto K; Okabe I; Hanawa Y; Hashizume K; Matsui I; Okawa H; Tsunoda A; Sakurai M
    Acta Paediatr Jpn; 1990 Dec; 32(6):725-33. PubMed ID: 2082676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mass screening for neuroblastoma in infants in Japan. Interim report of a mass screening study group.
    Sawada T; Hirayama M; Nakata T; Takeda T; Takasugi N; Mori T; Maeda K; Koide R; Hanawa Y; Tsunoda A
    Lancet; 1984 Aug; 2(8397):271-3. PubMed ID: 6146820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mass screening for neuroblastoma in infancy. The Japanese Mass Screening Study Group of Neuroblastoma.
    Sawada T; Sugimoto T; Matsumura T; Tunoda A; Takeda T; Yamamoto K; Koide R; Nagahara N; Hanawa Y; Nishihira K
    Prog Clin Biol Res; 1988; 271():525-34. PubMed ID: 3406016
    [No Abstract]   [Full Text] [Related]  

  • 8. VMA mass screening program of neuroblastoma for infants in Nagoya City, Japan.
    Kodama K; Nakata T; Ishii J; Mitani K; Tsunooka H; Masaoka A; Aoyama M
    Am J Public Health; 1985 Feb; 75(2):173-5. PubMed ID: 3966625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for neuroblastoma.
    Weinblatt M
    Pediatrics; 1988 Jan; 81(1):175-7. PubMed ID: 3336591
    [No Abstract]   [Full Text] [Related]  

  • 10. Screening for neuroblastoma.
    Lancet; 1987 Nov; 2(8569):1204. PubMed ID: 2890821
    [No Abstract]   [Full Text] [Related]  

  • 11. Mass screening in Japan increased the detection of infants with neuroblastoma without a decrease in cases in older children.
    Bessho F; Hashizume K; Nakajo T; Kamoshita S
    J Pediatr; 1991 Aug; 119(2):237-41. PubMed ID: 1861208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do children benefit from mass screening for neuroblastoma? Consensus Statement from the American Cancer Society Workshop on Neuroblastoma Screening.
    Murphy SB; Cohn SL; Craft AW; Woods WG; Sawada T; Castleberry RP; Levy HL; Prorok PC; Hammond GD
    Lancet; 1991 Feb; 337(8737):344-6. PubMed ID: 1671243
    [No Abstract]   [Full Text] [Related]  

  • 13. Past and future of neuroblastoma screening in Japan.
    Sawada T
    Am J Pediatr Hematol Oncol; 1992 Nov; 14(4):320-6. PubMed ID: 1456397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stephen L. Gans overseas lecture. Mass screening for neuroblastoma in Japan: lessons learned and future directions.
    Suita S
    J Pediatr Surg; 2002 Jul; 37(7):949-54. PubMed ID: 12077747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of neuroblastoma in Sapporo city.
    Nishi M; Miyake H; Takeda T; Shimada M; Takasugi N; Sato Y; Hanai J
    J Pediatr Surg; 1990 May; 25(5):545-6. PubMed ID: 2191108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Japanese mass screening for neuroblastoma.
    Kudo K; Arai Y; Kondo Y
    Lancet; 1998 Oct; 352(9136):1316. PubMed ID: 9788492
    [No Abstract]   [Full Text] [Related]  

  • 17. Analysis of 598 cases of neuroblastoma (NB) detected by screening and changes in the age distribution and incidence of NB patients after mass screening in infants in Japan. NB Screening Study Group.
    Sawada T; Shikata T; Matsumura T; Kawakatsu H; Sugimoto T
    Prog Clin Biol Res; 1994; 385():371-5. PubMed ID: 7972233
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of mass screening on age-specific incidence of neuroblastoma.
    Bessho F
    Int J Cancer; 1996 Aug; 67(4):520-2. PubMed ID: 8759611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Present status of neuroblastoma mass screening in Japan. Neuroblastoma-Committee of the Japanese Childhood Cancer Society].
    Sawada T; Nagahara N; Ohi R; Yamamoto K; Okabe I; Hanawa Y; Hashizume K; Matsui I; Ohkawa H; Tunoda A
    Gan To Kagaku Ryoho; 1990 Dec; 17(12):2319-26. PubMed ID: 2260868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The incidence and mortality rates of neuroblastoma cases before and after the cessation of the mass screening program in Japan: A descriptive study.
    Shinagawa T; Kitamura T; Katanoda K; Matsuda T; Ito Y; Sobue T
    Int J Cancer; 2017 Feb; 140(3):618-625. PubMed ID: 27778323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.